‘Mysterious’ Pneumonia Outbreaks Reported in China
News reports of outbreaks of a bacterial respiratory illness known as mycoplasma pneumoniae pneumonia (MPP) in northern China began to emerge in October 2023. The outbreaks, primarily among children, have been attributed by public health professionals to “declining immunity levels” in people as a result of “preventive measures” taken in over the past three years […]
FDA Panel Endorses New Alzheimer’s Drug After Accelerated Approval
The newest Alzheimer’s drug is on its way for full regulatory approval after a U.S. Food and Drug Administration (FDA) advisory panel voted that the drug was beneficial in slowing cognitive decline. The drug is expected to be fully approved by July 6, 2023.1 In clinical trials the drug, known as lecanemab, demonstrated a 27 […]
AAP Says Obese Children Should Be Treated “Aggressively” With Drugs and Surgery
New guidelines from the American Academy of Pediatrics (AAP) state that obese children should be evaluated and treated “early and aggressively” with medications or weight loss surgeries.1 This is the first guidance from the AAP in 15 years on childhood obesity, which affects more than 14.4 million children in the U.S. and has tripled in […]
Study Finds Aluminum in Vaccines May Raise Asthma Risks
A new federally funded study has found a possible association between aluminum-containing inactivated vaccines injected into children under age two and the risk of developing asthma before age five. Researchers are urging caution in interpretation of the results of the retrospective observational study and say more research is needed to confirm the findings.1 Researchers gathered […]
Research Linked to Leading Cause of Alzheimer’s Disease May Have Been Fabricated
For nearly two decades, Alzheimer’s disease research, research funding, and prescribed drugs have been centered around a 2006 research paper hypothesizing that the cognitive decline causing the debilitating disease is due to buildup in the brain of a protein called the amyloid beta (Aβ) protein. But a recent investigation is questioning whether the data in […]
CDC Distributing Monkeypox Vaccines Nationwide While Raising Monkeypox Travel Alert to Level 2
On June 6, 2022, the U.S. Centers for Disease Control and Prevention (CDC) raised its monkeypox travel alert to Level 2, warning Americans to “Practice Enhanced Precautions.”1 The agency stated that monkeypox cases have been rising in at least 29 countries, with 1,019 infections reported to date. Currently, the United States has confirmed 31 cases […]
